Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea

BACKGROUND: Tiotropium, a long-acting muscarinic antagonist, is recommended for add-on therapy to inhaled corticosteroids (ICS)-long-acting beta 2 agonists (LABA) for severe asthma. However, real-world studies on the predictors of response to tiotropium are limited. We investigated the real-world us...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Ji-Su, Jin, Juhae, Kim, Sae-Hoon, Lee, Taehoon, Jang, An-Soo, Park, Chan Sun, Jung, Jae-Woo, Kwon, Jae-Woo, Moon, Ji-Yong, Yang, Min-Suk, Lee, Jaechun, Choi, Jeong-Hee, Shin, Yoo Seob, Kim, Hee-Kyoo, Kim, Sujeong, Kim, Joo-Hee, Cho, Sang-Heon, Nam, Young-Hee, Kim, Sang-Hoon, Park, So Young, Hur, Gyu Young, Kim, Sang-Ha, Park, Hye-Kyung, Jin, Hyun Jung, Lee, Jae-Hyun, Park, Jung-Won, Yoon, Ho Joo, Choi, Byoung Whui, Cho, Young-Joo, Kim, Min-Hye, Kim, Tae-Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Full-Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679363/
https://www.ncbi.nlm.nih.gov/pubmed/36438190
http://dx.doi.org/10.1016/j.waojou.2022.100720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679363/
https://www.ncbi.nlm.nih.gov/pubmed/36438190
http://dx.doi.org/10.1016/j.waojou.2022.100720

Ejemplares similares